(Press-News.org) Medications commonly used to treat dementia could result in harmful weight loss, according to UC San Francisco researchers, and clinicians need to account for this risk when prescribing these drugs to older adults, they said.
Their study appears online and in the August issue of the Journal of the American Geriatrics Society.
"This is very relevant to patient care because unintentional weight loss in older adults is associated with many adverse outcomes, including increased rates of institutionalization and mortality, a decline in functional status, and poorer quality of life," said lead author Meera Sheffrin, MD, geriatrics fellow in the UCSF School of Medicine at the UCSF-affiliated San Francisco VA Medical Center. "Our study provides evidence in a large, real-world population that cholinesterase inhibitors may contribute to clinically significant weight loss in a substantial proportion of older adults with dementia."
Alzheimer's disease and other dementias are prevalent, affecting one in six people over age 80. The main drug treatments, a class of medications called cholinesterase inhibitors (i.e., donepezil, galantamine, rivastigmine), are marginally beneficial for most patients and may have serious side effects such as gastrointestinal symptoms.
Weight loss also is a significant problem in dementia patients and linked to increased mortality. Data from randomized controlled trials suggests this weight loss may be an under-recognized side effect of cholinesterase inhibitors, but evidence is limited and conflicting.
In this study, Sheffrin and her colleagues used national VA data from 2007-2010 to evaluate patients age 65 or older diagnosed with dementia who received a new prescription for a cholinesterase inhibitor or other new chronic medication. The primary outcome was timed to a 10-pound weight loss over a 12-month period, as this represents a degree of loss that would be noticed by a clinician and perhaps prompt further action in considering the causes and potential treatments.
A total of 1,188 patients started on cholinesterase inhibitors were matched to 2,189 patients started on other medications. At 12 months, 78 percent were still on the inhibitors, compared to 66 percent for other medications. About 29.3 percent of patients on the inhibitors experienced significant weight loss, compared to 22.8 percent of non-users.
These results demonstrated that patients started on the medications had a higher risk of clinically significant weight loss over a 12-month period compared to matched controls, Sheffrin said. Specifically, one out of every 21 patients treated experienced at least a 10-pound weight loss.
Further research is needed to validate these findings and address study limitations, including if there is a specific subgroup in which starting cholinesterase inhibitors had a higher risk of weight loss, as this study may have been underpowered to find those differences. The sample also included mainly older male veterans, so the generalizability of the findings to women is uncertain, the researchers said.
"Clinicians should take into account the risk of weight loss when weighing the risks and benefits of prescribing cholinesterase inhibitors in patients with dementia," the authors write. "In addition, clinicians should monitor for weight loss if these medications are prescribed and consider discontinuing cholinesterase inhibitors if significant weight loss occurs."
INFORMATION:
Other UCSF contributors to the Journal of the American Geriatrics Society study were senior author Mike Steinman, MD, associate professor, and Yinghui Miao, MD, MPH, statistician, of geriatrics; and W. John Boscardin, PhD, professor of epidemiology and biostatistics. Funding was provided by the National Institute on Aging and the American Federation on Aging Research.
UC San Francisco (UCSF) is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. It includes top-ranked graduate schools of dentistry, medicine, nursing and pharmacy, a graduate division with nationally renowned programs in basic, biomedical, translational and population sciences, as well as a preeminent biomedical research enterprise and two top-ranked hospitals, UCSF Medical Center and UCSF Benioff Children's Hospital San Francisco. Please visit http://www.ucsf.edu.
This news release is available in French.
TORONTO/MONTREAL - Cerebral palsy (CP) is the most common cause of physical disability in children. It has historically been considered to be caused by factors such as birth asphyxia, stroke and infections in the developing brain of babies. In a new game-changing Canadian study, a research team from The Hospital for Sick Children (SickKids) and the Research Institute of the McGill University Health Centre (RI-MUHC) has uncovered strong evidence for genetic causes of cerebral palsy that turns experts' understanding ...
Picky eating among children is a common but burdensome problem that can result in poor nutrition for kids, family conflict, and frustrated parents.
Although many families see picky eating as a phase, a new study from Duke Medicine finds moderate and severe picky eating often coincides with serious childhood issues such as depression and anxiety that may need intervention.
According to the study, published August 3 in the journal Pediatrics, more than 20 percent of children ages 2 to 6 are selective eaters. Of them, nearly 18 percent were classified as moderately picky. ...
PULLMAN, Wash.--Washington State University researchers say environmental factors are having an underappreciated effect on the course of disease and evolution by prompting genetic mutations through epigenetics, a process by which genes are turned on and off independent of an organism's DNA sequence.
Their assertion is a dramatic shift in how we might think of disease and evolution's underlying biology and "changes how we think about where things come from," said Michael Skinner, founding director of the Center for Reproductive Biology in WSU's School of Biological Sciences.
Skinner ...
Abstinence is the best way to avoid drug addiction. But in many societies, drug use is the norm, not the exception, especially by youth. What keeps the majority of users from becoming addicted? How drugs are taken has something to do with it, according to pharmacology researchers at the University of Montreal. "Why do some drug users become addicts? The amount of drugs they take over time is one factor, but the speed with which the substance enters and exits the brain can be just as important," explained Professor Anne-Noël Samaha, who supervised the study into how ...
Parents who joke and pretend with their children are teaching them important life skills, research by the University of Sheffield has revealed.
The study showed that children as young as 16 months old naturally learn the difference between joking and pretending by picking up on their parents' cues.
It also showed understanding the difference between the two allows children the opportunity to learn, imagine, bond, and think in abstract ways.
Researchers from the University's Department of Psychology carried out two studies; one involved parents being asked to joke ...
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body's immune cells, leaving them too physically drained to fight the disease, according to new research published in the journal Cancer Research today (Saturday).
Cancer Research UK-funded scientists have discovered that the cells in neuroblastoma - a rare type of childhood cancer that affects nerve cells - produce a molecule that breaks down arginine, one of the building blocks of proteins and an essential energy source for immune cells.
This molecule - called 'arginase' ...
COLUMBUS, Ohio--After debuting the world's first solar air battery last fall, researchers at The Ohio State University have now reached a new milestone.
In the Journal of the American Chemical Society, they report that their patent-pending design--which combines a solar cell and a battery into a single device--now achieves a 20 percent energy savings over traditional lithium-iodine batteries.
The 20 percent comes from sunlight, which is captured by a unique solar panel on top of the battery, explained Yiying Wu, professor of chemistry and biochemistry at Ohio State.
The ...
CLAREMONT, Calif. -- Conventional theories used by economists for the past 150 years to explain how societies buy, sell, and trade goods and services may be able to unlock mysteries about the behavior of microbial life on earth, according to a study by researchers from Claremont Graduate University, Boston University, and Columbia University.
The findings, published July 29 in the open access journal PLOS ONE, provide new insight into the behavior of the planet's oldest and tiniest life forms, and also create a new framework for examining larger questions about biological ...
Resettlement projects in the Amazon are driving severe tropical deforestation - according to new research from the University of East Anglia and Câmara dos Deputados (the Brazilian Lower House).
Widely hailed as a socially responsible and 'innocuous' strategy of land redistribution, agrarian reform settlements have been created throughout the Brazilian Amazon since the early 1970s at an unprecedented scale.
But a study published today in PLOS ONE reveals that these farmer resettlement projects are far from environmentally friendly or socio-economically beneficial. ...
Tempe, Ariz. -- When it comes to vaccinating their babies, bees don't have a choice -- they naturally immunize their offspring against specific diseases found in their environments. And now for the first time, scientists have discovered how they do it.
Researchers from Arizona State University, University of Helsinki, University of Jyväskylä and Norwegian University of Life Sciences made the discovery after studying a bee blood protein called vitellogenin. The scientists found that this protein plays a critical, but previously unknown role in providing bee babies ...
